Chemical synthesis of the ATAD2 bromodomain

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 8, 2014, Pages 2891-2896

  Creech, Gardner S ^a   Paresi, Chelsea ^a,b   Li, Yue Ming ^a,b   Danishefsky, Samuel J ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Medical Center   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Desulfurization; Peptide retrosynthesis; Solid phase peptide synthesis

Indexed keywords

ALANINE; ATAD2 PROTEIN; LEUCINE; PROLINE; PROTEIN; UNCLASSIFIED DRUG; VALINE;

ARTICLE; BROMODOMAIN; CHEMICAL MODIFICATION; CROSS REACTION; DESULFURIZATION; HYDROLYSIS; MASS FRAGMENTOGRAPHY; NATIVE CHEMICAL LIGATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

DESULFURIZATION; PEPTIDE RETROSYNTHESIS; SOLID-PHASE PEPTIDE SYNTHESIS;

ADENOSINE TRIPHOSPHATASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA-BINDING PROTEINS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; SOLID-PHASE SYNTHESIS TECHNIQUES;

EID: 84896844924     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1400556111     Document Type: Article

References (43)

1. Tamkun JW, et al. (1992) Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68(3):561-572.
2. Muller S, Filippakopoulos P, Knapp S (2011) Bromodomains as therapeutic targets. Expert Rev Mol Med 13:e29.
3. Denis GV, Nikolajczyk BS, Schnitzler GR (2010) An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis. FEBS Lett 584(15):3260-3268.
4. Denis GV (2010) Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation. Discov Med 10(55):489-499.
5. Barbieri I, Cannizzaro E, Dawson MA (2013) Bromodomains as therapeutic targets in cancer. Brief Funct Genomics 12(3):219-230.
6. Filippakopoulos P, et al. (2010) Selective inhibition of BET bromodomains. Nature 468(7327):1067-1073.
7. Nicodeme E, et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468(7327):1119-1123.
8. Ito T, et al. (2011) Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors. Chem Biol 18(4):495-507.
9. Chung CW, et al. (2011) Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem 54(11):3827-3838.
10. Dhalluin C, et al. (1999) Structure and ligand of a histone acetyltransferase bromo-domain. Nature 399(6735):491-496. (Pubitemid 29258857)
11. Zeng L, et al. (2005) Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J Am Chem Soc 127(8):2376-2377. (Pubitemid 40327786)
12. Boussouar F, Jamshidikia M, Morozumi Y, Rousseaux S, Khochbin S (2013) Malignant genome reprogramming by ATAD2. Biochim Biophys Acta 1829(10):1010-1014.
13. Hsia EY, Goodson ML, Zou JX, Privalsky ML, Chen HW (2010) Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv Drug Deliv Rev 62(13): 1227-1237.
14. Ciró M, et al. (2009) ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res 69(21):8491-8498.
15. Fouret R, et al. (2012) A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma. Clin Cancer Res 18(20):5606-5616.
16. Raeder MB, et al. (2013) Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLoS ONE 8(2):e54873.
17. Zou JX, Revenko AS, Li LB, Gemo AT, Chen HW (2007) ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci USA 104(46):18067-18072. (Pubitemid 350210821)
18. Zou JX, et al. (2009) Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer. Cancer Res 69(8):3339-3346.
19. Revenko AS, Kalashnikova EV, Gemo AT, Zou JX, Chen HW (2010) Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark. Mol Cell Biol 30(22):5260-5272.
20. Hsia EY, et al. (2010) Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer. Mol Cancer Res 8(2):183-193.
21. Altintas DM, et al. (2012) Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells. Mol Endocrinol 26(9):1531-1541.
22. Ramakrishna M, et al. (2010) Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis. PLoS ONE 5(4):e9983.
23. Kalashnikova EV, et al. (2010) ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res 70(22):9402-9412.
24. Caron C, et al. (2010) Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29(37): 5171-5181.
25. Fernandez SV, et al. (2013) Inflammatory breast cancer (IBC): Clues for targeted therapies. Breast Cancer Res Treat 140(1):23-33.
26. Zhang Y, et al. (2013) ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma. Ann Surg Oncol 20(Suppl 3):S577- S582.
27. Filippakopoulos P, et al. (2012) Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149(1):214-231.
28. Schumacher TN, et al. (1996) Identification of D-peptide ligands through mirror-image phage display. Science 271(5257):1854-1857.
29. Sun N, Funke SA, Willbold D (2012) Mirror image phage display - Generating stable therapeutically and diagnostically active peptides with biotechnological means. J Biotechnol 161(2):121-125.
30. Yeates TO, Kent SB (2012) Racemic protein crystallography. Annu Rev Biophys 41:41 - 61.
31. Dang B, Kubota T, Mandal K, Bezanilla F, Kent SB (2013) Native chemical ligation at Asx-Cys, Glx-Cys: Chemical synthesis and high-resolution X-ray structure of ShK toxin by racemic protein crystallography. J Am Chem Soc 135(32):11911-11919.
32. Dawson PE, Muir TW, Clark-Lewis I, Kent SB (1994) Synthesis of proteins by native chemical ligation. Science 266(5186):776-779. (Pubitemid 24359280)
33. Yan LZ, Dawson PE (2001) Synthesis of peptides and proteins without cysteine residues by native chemical ligation combined with desulfurization. J Am Chem Soc 123(4):526-533. (Pubitemid 32105995)
34. Wan Q, Danishefsky SJ (2007) Free-radical-based, specific desulfurization of cysteine: A powerful advance in the synthesis of polypeptides and glycopolypeptides. Angew Chem Int Ed Engl 46(48):9248-9252. (Pubitemid 350292152)
35. Bang D, Pentelute BL, Kent SB (2006) Kinetically controlled ligation for the convergent chemical synthesis of proteins. Angew Chem Int Ed Engl 45(24):3985-3988. (Pubitemid 44105704)
36. Karlström A, Undén A (1996) A new protecting group for aspartic acid that minimizes piperidine-catalyzed aspartimide formation in Fmoc solid phase peptide synthesis. Tetrahedron Lett 37(24):4243-4246.
37. Ullmann V, et al. (2012) Convergent solid-phase synthesis of N-glycopeptides facilitated by pseudoprolines at consensus-sequence Ser/Thr residues. Angew Chem Int Ed Engl 51(46):11566-11570.
38. Wang P, Aussedat B, Vohra Y, Danishefsky SJ (2012) An advance in the chemical synthesis of homogeneous N-linked glycopolypeptides by convergent aspartylation. Angew Chem Int Ed Engl 51(46):11571-11575.
39. Tan Z, Shang S, Danishefsky SJ (2010) Insights into the finer issues of native chemical ligation: An approach to cascade ligations. Angew Chem Int Ed Engl 49(49):9500 - 9503.
40. Villain M, Gaertner H, Botti P (2003) Native chemical ligation with aspartic and glutamic acids as C-terminal residues: Scope and limitations. Eur J Org Chem (17): 3267-3272.
41. Marriott G (1994) Caged protein conjugates and light-directed generation of protein activity: Preparation, photoactivation, and spectroscopic characterization of caged G-actin conjugates. Biochemistry 33(31):9092 - 9097.
42. Wojcik F, O'Brien AG, Götze S, Seeberger PH, Hartmann L (2013) Synthesis of carbohydrate- functionalised sequence-defined oligo(amidoamine)s by photochemical thiol-ene coupling in a continuous flow reactor. Chemistry 19(9):3090-3098.
43. Wright TH, et al. (2013) Direct peptide lipidation through thiol-ene coupling enables rapid synthesis and evaluation of self-adjuvanting vaccine candidates. Angew Chem Int Ed Engl 52(40):10616-10619.